SYNH Stock Recent News

SYNH LATEST HEADLINES

SYNH Stock News Image - globenewswire.com

Colin Shannon Appointed Executive Chairman Seasoned Executive Further Strengthens Company's Leadership Team MORRISVILLE, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Costa Panagos as CEO and a member of the Company's Board of Directors, effective immediately.

globenewswire.com 2024 Oct 09
SYNH Stock News Image - Zacks Investment Research

Syneos Health (SYNH) announces an expanded collaboration with Oracle to accelerate patient recruitment capabilities.

Zacks Investment Research 2023 Sep 13
SYNH Stock News Image - Zacks Investment Research

Syneos Health (SYNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research 2023 Jul 25
SYNH Stock News Image - Zacks Investment Research

Syneos Health (SYNH) partners with uMotif to deliver the patient-centric eClinical platform.

Zacks Investment Research 2023 Jun 27
SYNH Stock News Image - Zacks Investment Research

Syneos Health's (SYNH) purchase price represents a 24% premium to its unaffected closing stock price prior to the announcement. Margin pressure continues to weigh on the stock.

Zacks Investment Research 2023 Jun 07
SYNH Stock News Image - Zacks Investment Research

Syneos Health (SYNH) is set to become private company following a $7.1 billion merger deal to be acquired by a private investment consortium.

Zacks Investment Research 2023 May 11
SYNH Stock News Image - Zacks Investment Research

Syneos Health (SYNH) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $1.01 per share a year ago.

Zacks Investment Research 2023 May 10
SYNH Stock News Image - InvestorPlace

Syneos Health (NASDAQ: SYNH ) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal. A group of investors led by Elliott Investment Management intend to take the healthcare company private for a price of $43 per share.

InvestorPlace 2023 May 10
SYNH Stock News Image - Barrons

The sale of Syneos Health comes as the company faces muted spending from drug developers for its clinical-research services.

Barrons 2023 May 10
SYNH Stock News Image - Market Watch

Syneos Health Inc.'s SYNH stock surged 19% in extended trading Tuesday on a Bloomberg report that a consortium of Elliott Investment Management, Patient Square Capital and Veritas Capital is in advanced talks to acquire Syneos, a drug-research services company. A deal could be announced as soon as this week, according to people with knowledge of the talks, the report said.

Market Watch 2023 May 09
10 of 37